Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Typhoid polysaccharide 25micrograms/0.5ml vacc inj pfs
1404000S0AAADAD
|
Typhoid Vaccine | Typhoid | Immunological Products and Vaccines | 2,294 |
|
Fluarix Tetra vacc inj 0.5ml pre-filled syringes
1404000H0BUAAAK
|
Fluarix Tetra | Influenza | Immunological Products and Vaccines | 2,083 |
|
Diphtheria/Tetanus/IPV vacc (ads) inj 0.5ml pfs
1404000F0AAAWAW
|
Diphtheria | Diphtheria | Immunological Products and Vaccines | 2,045 |
|
VAQTA Paediatric vacc inj 0.5ml pre-filled syringes
140400030BDAAAD
|
VAQTA | Hepatitis A | Immunological Products and Vaccines | 2,009 |
|
ViATIM vacc inj 1ml pre-filled syringes
1404000ADBCAAAB
|
ViATIM | Hepatitis A/typhoid vaccine | Immunological Products and Vaccines | 1,994 |
|
Trivalent Flu/Vac/SA inj 0.5ml pfs
1404000H0AAARAR
|
Influenza | Influenza | Immunological Products and Vaccines | 1,258 |
|
Dukoral cholera vaccine oral suspension
1404000E0BFAAAJ
|
Dukoral | Cholera | Immunological Products and Vaccines | 1,188 |
|
M-M-RVAXPRO vacc inj 0.5ml pre-filled syringes
1404000W0BIAAAD
|
M-M-RVAXPRO | Measles, mumps and rubella vaccine | Immunological Products and Vaccines | 967 |
|
Shingrix (Herpes Zoster) adjuvanted rcmb vacc inj 0.5ml
1404000ALBCABAC
|
Shingrix | Shingles (H/Z) | Immunological Products and Vaccines | 943 |
|
Engerix B 20micrograms/1ml vacc inj vials
1404000G0BCAAAB
|
Engerix B | Hepatitis B | Immunological Products and Vaccines | 939 |
|
Imuvac vacc inj 0.5ml pre-filled syringes
1404000H0BNAAAF
|
Imuvac | Influenza | Immunological Products and Vaccines | 818 |
|
Ambirix vacc inj 1ml pre-filled syringes
140400070BCAAAA
|
Ambirix | Hepatitis A/hepatitis B | Immunological Products and Vaccines | 745 |
|
Abrysvo vaccine inj 0.5ml vials
1404000AWBCAAAB
|
Abrysvo | Respiratory Syncytial Virus (RSV) | Immunological Products and Vaccines | 691 |
|
Zostavax vacc inj 0.65ml pfs
1404000ALBBAAAA
|
Zostavax | Shingles (H/Z) | Immunological Products and Vaccines | 625 |
|
Twinrix Paediatric vacc inj 0.5ml pre-filled syringes
140400070BBABAB
|
Twinrix | Hepatitis A/hepatitis B | Immunological Products and Vaccines | 611 |
|
Priorix vacc inj 0.5ml pre-filled syringes
1404000W0BHABAE
|
Priorix | Measles, mumps and rubella vaccine | Immunological Products and Vaccines | 588 |
|
Bexsero vacc inj 0.5ml pre-filled syringes
1404000AQBBAAAA
|
Bexsero | Meningococcal B vaccine | Immunological Products and Vaccines | 439 |
|
Fendrix 20micrograms/0.5ml vacc inj pre-filled syringes
1404000G0BGAAAJ
|
Fendrix | Hepatitis B | Immunological Products and Vaccines | 436 |
|
HBVAXPRO 10micrograms/1ml vacc inj pre-filled syringes
1404000G0BEAEAE
|
HBVAXPRO | Hepatitis B | Immunological Products and Vaccines | 388 |
|
Prevenar 13 vacc inj 0.5ml pre-filled syringes
1404000L0BEACAF
|
Prevenar | Pneumococcal | Immunological Products and Vaccines | 369 |
|
Nimenrix vacc inj 0.5ml pre-filled syringes
1404000X0BJAAAG
|
Nimenrix | Meningococcal A + C + W135 + Y vaccine | Immunological Products and Vaccines | 350 |
|
Cholera vaccine oral suspension and vehicle
1404000E0AAAJAJ
|
Cholera (Vaccine) | Cholera | Immunological Products and Vaccines | 345 |
|
Shingles (Herpes Zoster) vacc (live) inj 0.65ml pfs
1404000ALAAAAAA
|
Shingles (H/Z) | Shingles (H/Z) | Immunological Products and Vaccines | 327 |
|
HBvaxPRO 40micrograms/1ml vacc inj vials
1404000G0BEACAG
|
HBVAXPRO | Hepatitis B | Immunological Products and Vaccines | 290 |
|
Respiratory Syncytial Virus (RSV) vacc (bivalent, rcmb) inj
1404000AWAAABAB
|
Respiratory Syncytial Virus (RSV) vaccine | Respiratory Syncytial Virus (RSV) | Immunological Products and Vaccines | 277 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.